GPER1 and benign prostatic hyperplasia: Moreover, mechanism dissection suggested the CYP19/estrogen/G protein-coupled estrogen receptor (GPER)/Gαi signaling pathway may be involved in the regulation of stromal cell proliferation and prostatic fibrosis, which may function to accelerate the clinical progression of patients with BPH.